Pharma M&A and venture capital deals reach $33.7 billion in Jan 2025 GlobalData Feb 7, 2025 Johnson & Johnson, Eli Lilly, and Gilead Sciences lead M&A activity; Venture capital investments increase by 62.1 per cent…
